§ 16-42-22-8 — Requirements for substitution

(a) For substitution to occur for a prescription
other than a prescription filled under the Medicaid program (42 U.S.C.
1396 et seq.), the children's health insurance program established under
IC 12-17.6-2, the biosimilar biological products requirements under IC 16-42-25, or the Medicare program (42 U.S.C. 1395 et seq.):
(1) the practitioner must:
(A) sign on the line under which the words "May substitute"
appear; or
(B) for an electronically transmitted prescription, electronically
transmit the instruction "May substitute."; and
(2) the pharmacist must inform the customer of the substitution.
(b) This section does not authorize any substitution other than
substitution of a generically equivalent drug product.
[Pre-1993 Recodification Citation: 16-6-8.1-2(c).]

Legislative History

As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.7; P.L.291-2001, SEC.233; P.L.204-2005, SEC.10; P.L.96-2014, SEC.5.